Evidence map›Paper›PMID 42434041›Full record

ArticleSkin appendage disorders2026

Additive Effects of Platelet-Rich Plasma and Systemic Therapies in Androgenetic Alopecia: A Retrospective Study.

Anna L Brinks, Carli Needle Lawrence, Derek Maas, Caitlin A Kearney, Nnaemeka Anyanwu, Deesha D Desai, Ambika Nohria, Michelle Sikora, Christina S Oh, Jerry Shapiro and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Skin appendage disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anna L BrinksThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
Carli Needle LawrenceThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
Derek MaasThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
Caitlin A KearneyThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
Nnaemeka AnyanwuThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
Deesha D DesaiThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
Ambika NohriaThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
Michelle SikoraThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
Christina S OhThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
Jerry ShapiroThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
Kristen I Lo SiccoThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Established treatments for androgenetic alopecia (AGA) include low-dose oral minoxidil (LDOM), spironolactone, finasteride, dutasteride, and platelet-rich plasma (PRP). While PRP is often combined with topical minoxidil, studies on its use with systemic agents are limited. This study compares trichometric outcomes and side effects between PRP monotherapy and PRP plus systemic therapy. Methods: An IRB-approved retrospective review was conducted of NYU AGA patients treated between 11/1/17 and 8/1/25. Changes in hair density (hairs/cm Results: Fifty-five patients met inclusion criteria (65.5% female, mean age 49). Compared to monotherapy ( Conclusions: Combination therapy showed numerically higher but statistically nonsignificant improvements without increased adverse effects. These findings support further prospective studies to optimize combination regimens and patient selection by AGA severity.

Indexed as

Androgenetic alopeciaDutasterideFinasterideLow-dose oral minoxidilPlatelet-rich plasmaSpironolactone

Identifiers

PMID42434041
PMCPMC13354296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.